OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

All‐In‐One Biomimetic Nanoplatform Based on Hollow Polydopamine Nanoparticles for Synergistically Enhanced Radiotherapy of Colon Cancer
Liuyun Gong, Yujie Zhang, Jing Zhao, et al.
Small (2022) Vol. 18, Iss. 14
Closed Access | Times Cited: 74

Showing 26-50 of 74 citing articles:

Emerging Nanoagents for Medical X-ray Imaging
Qinxia Wu, Qianyu Zheng, Yu He, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 1, pp. 33-48
Closed Access | Times Cited: 14

Synergistic therapeutic effect of nanomotors triggered by Near-infrared light and acidic conditions of tumor
Shirong Zhang, Xuan Liu, Yijie Hao, et al.
Journal of Colloid and Interface Science (2023) Vol. 650, pp. 67-80
Closed Access | Times Cited: 14

Microneedle‐Delivered PDA@Exo for Multifaceted Osteoarthritis Treatment via PI3K‐Akt‐mTOR Pathway
Zihua Li, Hengli Lu, Limin Fan, et al.
Advanced Science (2024) Vol. 11, Iss. 42
Open Access | Times Cited: 4

Biomembrane‐coated nanosystems as next‐generation delivery systems for the treatment of gastrointestinal cancers
Joana Lopes, Daniela Lopes, Mahzad Motallebi, et al.
Bioengineering & Translational Medicine (2025)
Open Access

Recent progress in cancer cell membrane-based nanoparticles for biomedical applications
Qixiong Lin, Yueyou Peng, Yanyan Wen, et al.
Beilstein Journal of Nanotechnology (2023) Vol. 14, pp. 262-279
Open Access | Times Cited: 11

Colorectal cancer therapy mediated by nanomedicines
Shaopeng Zhang, Hao Zhang, Peizhe Song, et al.
Chemical Communications (2023) Vol. 59, Iss. 30, pp. 4423-4435
Closed Access | Times Cited: 11

Polydopamine nanomaterials and their potential applications in the treatment of autoimmune diseases
Manxiang Wu, Chengyuan Hong, Chunjuan Shen, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 11

Integration of Activation by Hypoxia and Inhibition Resistance of Tumor Cells to Apoptosis for Precise and Augmented Photodynamic Therapy
Yutong Shao, Miaomiao Chen, Wenlong Chen, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 25
Closed Access | Times Cited: 9

Cancer Cell Membrane‐Based Materials for Biomedical Applications
Yongping Lu, Linming Fan, Jun Wang, et al.
Small (2023) Vol. 20, Iss. 7
Open Access | Times Cited: 9

Tumor microenvironment-responsive degradable silica nanoparticles: design principles and precision theranostic applications
Junjie Zhang, Kaiyuan Tang, Zilu Liu, et al.
Nanoscale Horizons (2023) Vol. 9, Iss. 2, pp. 186-214
Closed Access | Times Cited: 9

A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistance
Mengyao Xu, Zhi-Yu Xia, Jian‐Xuan Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3

Glutathione‐Depleted Photodynamic Nanoadjuvant for Triggering Nonferrous Ferroptosis to Amplify Radiotherapy of Breast Cancer
Jiangnan Shi, Guoqing Cui, Yongmei M. Jin, et al.
Advanced Healthcare Materials (2024)
Open Access | Times Cited: 3

Nanomedicine-based multimodal therapies: Recent progress and perspectives in colon cancer
Yuchu He, Zi-Ning Hao, Zhuo Li, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 4, pp. 670-681
Open Access | Times Cited: 8

Plant-derived nanovesicles as an emerging platform for cancer therapy
Hanzhe Liu, Guo‐Feng Luo, Z. J. Shang
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 133-154
Open Access | Times Cited: 8

Frontiers in Preparations and Promising Applications of Mesoporous Polydopamine for Cancer Diagnosis and Treatment
Hualin Ma, Jingwen Peng, Jianing Zhang, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 15-15
Open Access | Times Cited: 13

Recent theranostic applications of hydrogen peroxide-responsive nanomaterials for multiple diseases
Linjie Huang, Yina Su, Dongdong Zhang, et al.
RSC Advances (2023) Vol. 13, Iss. 39, pp. 27333-27358
Open Access | Times Cited: 7

Dual-targeting of tumor cells and subcellular endoplasmic reticulum via AgPPIX-based Janus nanoparticles for photodynamic/immunotherapy against TNBC
Kun Ma, He Diao, Xiangyi Xu, et al.
Nanoscale (2024) Vol. 16, Iss. 25, pp. 12095-12106
Closed Access | Times Cited: 2

Blocking CX3CR1+ Tumor-Associated Macrophages Enhances the Efficacy of Anti-PD1 Therapy in Hepatocellular Carcinoma
Xiaonan Xiang, Kai Wang, Hui Zhang, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 11, pp. 1603-1620
Closed Access | Times Cited: 2

Nanozyme Decorated Metal-Organic Framework Nanosheet for Enhanced Photodynamic Therapy Against Hypoxic Tumor
Jiong Li, Dongqin Lei, Yanbing Cao, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9727-9739
Open Access | Times Cited: 2

Programmable Nanomodulators for Precision Therapy, Engineering Tumor Metabolism to Enhance Therapeutic Efficacy
Siwei Liu, Zhijun Liu, Huajiang Lei, et al.
Advanced Healthcare Materials (2024) Vol. 14, Iss. 4
Closed Access | Times Cited: 2

Reversing Immune Suppression and Potentiating Photothermal Immunotherapy via Bispecific Immune Checkpoint Inhibitor Loaded Hollow Polydopamine Nanospheres
Kai Guo, Dong Chen, Shuai Ren, et al.
ACS Applied Materials & Interfaces (2023)
Closed Access | Times Cited: 5

Colorectal cancer cell exosome and cytoplasmic membrane for homotypic delivery of therapeutic molecules
Ivana Jarak, Ana Isabel Santos, Ana Helena Pinto, et al.
International Journal of Pharmaceutics (2023) Vol. 646, pp. 123456-123456
Open Access | Times Cited: 5

A Biomimetic Nanomedicine Targets Orthotopic Glioblastoma by Combinatorial Co‐Delivery of Temozolomide and a Methylguanine‐DNA Methyltransferase Inhibitor
Yibin Wang, Yajing Sun, Nan Geng, et al.
Advanced Therapeutics (2022) Vol. 5, Iss. 12
Closed Access | Times Cited: 8

Scroll to top